Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 424

1.

Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.

Pillay NS, Kellaway LA, Kotwal GJ.

Behav Brain Res. 2008 Oct 10;192(2):173-7. doi: 10.1016/j.bbr.2008.03.038. Epub 2008 Apr 7.

PMID:
18490064
2.

Intracranial administration of vaccinia virus complement control protein in Mo/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test.

Kulkarni AP, Pillay NS, Kellaway LA, Kotwal GJ.

Biogerontology. 2008 Dec;9(6):405-20. doi: 10.1007/s10522-008-9161-7. Epub 2008 Aug 5.

PMID:
18679819
3.

Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.

O'Leary TP, Brown RE.

Behav Brain Res. 2009 Jul 19;201(1):120-7. doi: 10.1016/j.bbr.2009.01.039. Epub 2009 Feb 6.

PMID:
19428625
4.

Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.

Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.

Neurobiol Dis. 2005 Apr;18(3):602-17.

PMID:
15755686
5.

Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.

Melnikova T, Savonenko A, Wang Q, Liang X, Hand T, Wu L, Kaufmann WE, Vehmas A, Andreasson KI.

Neuroscience. 2006 Sep 1;141(3):1149-62. Epub 2006 Jun 6.

PMID:
16753269
6.

Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.

Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.

Behav Brain Res. 2011 Sep 23;222(2):342-50. doi: 10.1016/j.bbr.2011.03.072. Epub 2011 Apr 14.

PMID:
21513747
7.

Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.

Frye CA, Walf AA.

Neurobiol Learn Mem. 2008 Jan;89(1):17-26. Epub 2007 Nov 7.

PMID:
17988898
8.

A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.

Jeon S, Bose S, Hur J, Jun K, Kim YK, Cho KS, Koo BS.

J Ethnopharmacol. 2011 Sep 1;137(1):783-9. doi: 10.1016/j.jep.2011.06.046. Epub 2011 Jul 5.

PMID:
21762767
9.

Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.

Heikkinen T, Kalesnykas G, Rissanen A, Tapiola T, Iivonen S, Wang J, Chaudhuri J, Tanila H, Miettinen R, Puoliväli J.

Exp Neurol. 2004 May;187(1):105-17.

PMID:
15081593
10.

Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.

Ognibene E, Middei S, Daniele S, Adriani W, Ghirardi O, Caprioli A, Laviola G.

Behav Brain Res. 2005 Jan 30;156(2):225-32.

PMID:
15582108
11.

The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease.

Westerman MA, Cooper-Blacketer D, Mariash A, Kotilinek L, Kawarabayashi T, Younkin LH, Carlson GA, Younkin SG, Ashe KH.

J Neurosci. 2002 Mar 1;22(5):1858-67.

12.
13.

Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease.

Ambrée O, Richter H, Sachser N, Lewejohann L, Dere E, de Souza Silva MA, Herring A, Keyvani K, Paulus W, Schäbitz WR.

Neurobiol Aging. 2009 Aug;30(8):1192-204. Epub 2008 Feb 20.

PMID:
18079024
14.

Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease.

Reiserer RS, Harrison FE, Syverud DC, McDonald MP.

Genes Brain Behav. 2007 Feb;6(1):54-65.

15.
16.

Induced LC degeneration in APP/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits.

Jardanhazi-Kurutz D, Kummer MP, Terwel D, Vogel K, Dyrks T, Thiele A, Heneka MT.

Neurochem Int. 2010 Nov;57(4):375-82. doi: 10.1016/j.neuint.2010.02.001. Epub 2010 Feb 6.

PMID:
20144675
17.

A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.

Bonardi C, de Pulford F, Jennings D, Pardon MC.

Behav Brain Res. 2011 Sep 12;222(1):89-97. doi: 10.1016/j.bbr.2011.03.041. Epub 2011 Mar 31.

PMID:
21440575
18.

Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.

Stover KR, Brown RE.

Behav Brain Res. 2012 May 16;231(1):75-85. doi: 10.1016/j.bbr.2012.02.044. Epub 2012 Mar 3.

PMID:
22409975
19.

Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.

Kawasumi M, Chiba T, Yamada M, Miyamae-Kaneko M, Matsuoka M, Nakahara J, Tomita T, Iwatsubo T, Kato S, Aiso S, Nishimoto I, Kouyama K.

Eur J Neurosci. 2004 May;19(10):2826-38.

PMID:
15147316
20.

Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.

Arendash GW, Schleif W, Rezai-Zadeh K, Jackson EK, Zacharia LC, Cracchiolo JR, Shippy D, Tan J.

Neuroscience. 2006 Nov 3;142(4):941-52. Epub 2006 Aug 28.

PMID:
16938404

Supplemental Content

Support Center